Back to top
more

Motus GI (MOTS)

(Delayed Data from OTC)

$0.07 USD

0.07
16,588

0.00 (0.14%)

Updated May 10, 2024 03:26 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value B Growth D Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 37% (158 out of 250)

Industry: Medical Info Systems

Better trading starts here.

Zacks News

Cue Health Inc. (HLTH) Reports Q4 Loss, Tops Revenue Estimates

Cue Health Inc. (HLTH) delivered earnings and revenue surprises of 28.89% and 6.81%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

Nyxoah SA (NYXH) Reports Q4 Loss, Misses Revenue Estimates

Nyxoah SA (NYXH) delivered earnings and revenue surprises of 0% and 2.39%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

Computer Programs and Systems (CPSI) Q4 Earnings and Revenues Surpass Estimates

Computer Programs and Systems (CPSI) delivered earnings and revenue surprises of 5.88% and 2.83%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

Tenet Healthcare (THC) Q4 Earnings Beat on Hospital Operations

Tenet Healthcare (THC) expects net operating revenues to be between $19.9 billion and $20.3 billion in 2024.

Zacks.com featured highlights Lancaster Colony, On Holding, Rent the Runway, 5E Advanced Materials and Motus GI

Lancaster Colony, On Holding, Rent the Runway, 5E Advanced Materials and Motus GI have been highlighted in this Screen of The Week article.

Sanghamitra Saha headshot

Why You Should Bet on 5 Top-Ranked Stocks With Rising P/E

Tap five stocks with increasing P/E ratios to try out an out-of-the-box approach. These stocks include Lancaster Colony (LANC), On Holding (ONON), Rent the Runway (RENT), 5E Advanced Materials (FEAM) and Motus GI (MOTS).

Cigna (CI) Q4 Earnings Beat on Membership Growth, Dividend Up

Cigna (CI) expects adjusted revenues to register a minimum growth of 20.3% from the 2023 reported figure.

Humana (HUM) Q4 Earnings Miss on Higher Costs, '25 Target Pulled

Humana (HUM) expects 2024 revenues to increase to around $113 billion.

Elevance (ELV) Q4 Earnings Beat on Premium Growth, Dividend Hiked

Elevance Health (ELV) expects 2024 premium revenues to remain in line with the 2023 level.

Molina Healthcare (MOH) Up 26.9% in 6 Months: What Lies Ahead?

Molina Healthcare (MOH) is likely to keep growing on the back of increases in investment income and Medicare premiums.

Why You Should Retain Elevance (ELV) Stock in Your Portfolio

Elevance's (ELV) Carelon unit is expected to benefit from improving performance in the Behavioral Health business and post-acute care services.

UnitedHealth (UNH) Stock Declines 3.4% on High Medical Costs

As more seniors resume elective procedures, claims rise in UnitedHealth's (UNH) Medicare Advantage business.

Elevance Health (ELV) & Verizon Partner to Bring Health Equity

Elevance Health (ELV) launches a new program with an Affordable Connectivity Program offering free smartphones to eligible members.

Brookdale (BKD) Sees Growth in December 2023 Occupancy Volumes

Brookdale (BKD) witnesses a continuous streak of 26 months of year-over-year increases in the weighted average occupancy level.

Why Acadia (ACHC) is a Smart Addition to Your Portfolio Now

Acadia Healthcare's (ACHC) top line is poised to gain from rising admissions and patient days.

Why Community Health (CYH) Shares Are Attracting Investors Now

We expect Community Health's (CYH) occupancy rate to continue moving upward, reflecting improving utilization of its facilities and services.

Ensign (ENSG) Buys 2 Nursing Facilities in Tennessee & Nevada

The acquisition deals have increased Ensign's (ENSG) portfolio to encompass 299 healthcare operations spanning 14 states.

Reasons to Retain HCA Healthcare (HCA) Stock in Your Portfolio

HCA Healthcare's (HCA) improving top line, acquisition initiatives and a robust growth outlook poise the company well for growth.

Why You Should Retain Cigna (CI) Stock in Your Portfolio

Cigna's (CI) strong Evernorth and Cigna Healthcare segments, growing medical membership and a positive 2023 outlook poise it well for growth.

Molina (MOH) to Pay Lower Price for California Medicare Buyout

Molina Healthcare's (MOH) new price for Bright HealthCare's California Medicare business constitutes 23% of the anticipated $1.8 billion premium revenues for 2023.

Here's Why Investors Should Hold Elevance (ELV) Stock for Now

Elevance's (ELV) Carelon unit will see growth due to improving performance in post-acute care services and Behavioral Health business.

Centene (CNC) Unveils its 2024 Projections: Key Takeaways

Centene's (CNC) board boosts its share buyback program with a new $4 billion fund.

Cigna (CI) Adds $10B to Buyback Funds, Turns to Bolt-On Buyouts

Cigna (CI) expects to maintain average annual adjusted EPS growth within 10-13% in the long term.

Evaluating Acadia Healthcare's (ACHC) Future View: Hold or Fold?

Acadia Healthcare's (ACHC) top line is poised to capitalize on increasing patient days and bed capacity.

HCA Healthcare's (HCA) Houston Affiliate Acquires 11 EDs

The deal helps HCA Healthcare (HCA) boost its freestanding EDs in the Houston region to 26, supplementing its existing hospital-based emergency rooms.